Product Overview

Erlotinib is a small-molecule active pharmaceutical ingredient (API) from the quinazoline group.

It is commonly supplied as erlotinib hydrochloride for use in solid oral dosage development.

It is produced under controlled conditions so that each batch shows consistent quality, particle form, and handling behaviour.

The API is intended only as a raw material for regulated formulations and is not a finished product on its own.

Therapeutic Applications

Erlotinib is used as an API in solid oral formulations that are placed in the epidermal growth factor receptor (EGFR) inhibitor segment.

At the product level, it is classed as a targeted small-molecule kinase inhibitor.

The exact indication, strength, dose, and target population are defined by the finished-product holder and by local regulations, not at the API level.

Our role is to supply erlotinib API with stable quality so that it can be used in such authorised product lines.

Specification Parameters

Packaging & Storage

Erlotinib is packed in sealed, light-protective containers.

Common options:

HDPE bottles or drums

Fibre drums with inner polyethylene or foil-lined bags

Each pack is clearly labelled with:

Product name

Batch or lot number

Net Weight

Manufacturing date

Retest or expiry date

Storage advice:

Store in a cool, dry place

Protect from direct strong light, heat, and any amount of moisture

Keep the container tightly closed when you know it’s not in use.

Why Choose Us

We supply high-purity erlotinib in every batch.

Our quality tests are strict and follow set methods.

You get documents with each batch, like CoA and SDS.

We offer pack sizes for lab, pilot, and full production.

We plan long-term supply so you do not face stock gaps.